Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer
Clinical trial NCT03599362 · TERMINATED
Trial details
- NCT number
- NCT03599362
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2020-06-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.